On the necessity of specialized knowledge-based models for SBRT prostate treatments plans
•Standard fractionation KBP models compared to SBRT KBP model for prostate treatment.•The two KBP models have comparable outcome performance.•The model with larger sample has better predictive capabilities.•Well trained KBP model can be used successfully outside training boundaries. Test whether a w...
Gespeichert in:
Veröffentlicht in: | Physica medica 2024-05, Vol.121, p.103364-103364, Article 103364 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Standard fractionation KBP models compared to SBRT KBP model for prostate treatment.•The two KBP models have comparable outcome performance.•The model with larger sample has better predictive capabilities.•Well trained KBP model can be used successfully outside training boundaries.
Test whether a well-grounded KBP model trained on moderately hypo-fractionated prostate treatments can be used to satisfactorily drive the optimization of SBRT prostate treatments.
A KBP model (SBRT-model) was developed, trained and validated using the first forty-seven clinically treated VMAT SBRT prostate plans (42.7 Gy/7fx or 36.25 Gy/5fx). The performance and robustness of this model were compared against a high-quality KBP-model (ST-model) that was already clinically adopted for hypo-fractionated (70 Gy/28fx and 60 Gy/20fx) prostate treatments. The two models were compared in terms of their predictions robustness, and the quality of their outcomes were evaluated against a set of reference clinical SBRT plans. Plan quality was assessed using DVH metrics, blinded clinical ranking, and a dedicated Plan Quality Metric algorithm.
The plan libraries of the two models were found to share a high degree of anatomical similarity. The overall quality (APQM%) of the plans obtained both with the ST- and SBRT-models was compatible with that of the original clinical plans, namely (93.7 ± 4.1)% and (91.6 ± 3.9)% vs (92.8.9 ± 3.6)%. Plans obtained with the ST-model showed significantly higher target coverage (PTV V95%): (97.9 ± 0.8)% vs (97.1 ± 0.9)% (p |
---|---|
ISSN: | 1120-1797 1724-191X |
DOI: | 10.1016/j.ejmp.2024.103364 |